Detalhe da pesquisa
1.
Dual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cells.
Mol Pharmacol
; 87(6): 1006-12, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25829060
2.
Racial disparities in the association between variants on 8q24 and prostate cancer: a systematic review and meta-analysis.
Oncologist
; 17(3): 312-20, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22382457
3.
Multi-institutional Study of Outcomes After Pediatric Heart Transplantation: Candidate Gene Polymorphism Analysis of ABCC2.
J Pediatr Pharmacol Ther
; 19(1): 16-24, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24782687
4.
Bcl-2 family of proteins as therapeutic targets in genitourinary neoplasms.
Clin Genitourin Cancer
; 11(1): 10-9, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23083798
5.
Transporter pharmacogenetics: transporter polymorphisms affect normal physiology, diseases, and pharmacotherapy.
Discov Med
; 13(68): 19-34, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22284781
6.
Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemia.
Clin Cancer Res
; 18(7): 2099-107, 2012 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22307138
7.
Prostate cancer genomic signature offers prognostic value.
Cancer Biol Ther
; 10(11): 1079-80, 2010 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21088497